NBY - NovaBay Pharmaceuticals, Inc.
0.5598
0.030 5.341%
Share volume: 20,273
Last Updated: 04-14-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.53
0.03
0.06%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-07-2024 | |
| Total revenue | 2.441 M | |
| Cost of revenue | 848.000 K | |
| Gross profit | 1.593 M | |
| Operating expenses | 1.707 M | |
| Selling general and admin | 1.703 M | |
| Research and development | 4.000 K | |
| Total expenses | 2.654 M | |
| Operating income | -1.061 M | |
| Ebit | -1.061 M | |
| Pretax income | -1.212 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -1.212 M | |
